This is a two-part webinar to be held on December 9, 2020 from 1PM – 2:30PM Central Time and on December 16, 2020 from 1PM – 2:30PM Central Time.
Title: Medication Updates 2020 Part 1 & 2
Session Description (Part 1): This session reviews the process of getting a drug to market by a pharmaceutical company and the requirements imposed by the FDA for such. It continues with several disease states and the medications developed in the last year to address some of the ongoing needs of patients, especially individuals with I/DD. The disease states and new drugs discussed are Parkinson’s Disease, Alzheimer’s Disease and Depression.
Session Description (Part 2): This session continues with a discussion of disease states affecting the individual with I/DD and new drugs developed over the past year. The following topics are reviewed: Insomnia, Schizophrenia, Hypertension and Seizure Disorder. Lastly what is on the horizon for development is reviewed.
